Chronic Respiratory Symptoms

SAN DIEGO — Amikacin for 6 months improved respiratory symptoms in adults with newly diagnosed or recurrent Mycobacterium avium complex lung disease, according to a presentation at the American Thoracic Society International Conference.

Using artificial intelligence for patient triaging has the potential to streamline health care services while also tackling issues like antibiotic resistance, according to researchers.

Chronic respiratory symptoms in young adulthood were associated with increased risk for cardiovascular disease and all-cause mortality in midlife, independent of CV risk factors, smoking and lung function, researchers reported in Chest.